The global Biofeedback Measurement Instrument Market Growth Accelerated by Rising Demand for Stress Management and Wellbeing
Biofeedback measurement instruments help monitor and record physiological indicators of the body like brain waves, heart rate, breathing, muscle activity and skin temperature. They help understand the responses of the autonomic nervous system and aid in conditions like stress, anxiety, depression and chronic pain.
The
global Biofeedback Measurement Instrument Market is estimated to be valued at
US$ 185.4 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted
in a new report published by Coherent Market Insights.
Market key trends:
With
rising awareness about the benefits of stress management and well-being, the
demand for biofeedback therapy has increased substantially over the years.
Biofeedback treatment helps monitor stress levels in the body and control the
autonomic nervous system through visual or auditory feedback. This has resulted
in growing sales of biofeedback measurement instruments globally. Technological
advancements have made these devices more portable and easy-to-use, further
propelling the biofeedback measurement instrument market growth.
Segment Analysis
The global
biofeedback measurement instrument market size is dominated by the
healthcare segment. The healthcare segment accounts for over 65% share of the
total market owing to rising adoption of biofeedback therapy in pain
management, headache treatment, hypertension treatment and other conditions.
Within the healthcare segment, rehabilitation centers hold the major share
followed by hospitals. The growing need for non-drug and non-invasive pain
management therapies is driving the demand for biofeedback instruments across
various rehabilitation centers.
Key Takeaways
The global biofeedback measurement instrument market is expected to witness
high growth over the forecast period of 2023-2030. Favorable reimbursement
policies and growing acceptance of alternative therapies for chronic conditions
across major countries is supporting the market expansion. The global
Biofeedback Measurement Instrument Market is estimated to be valued at US$
185.4 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast
period 2023 to 2030.
North America currently dominates the global market and is expected to maintain
its top position during the forecast period. Growing healthcare expenditure,
advanced healthcare infrastructure and increasing prevalence of lifestyle
diseases are some major factors fueling the demand for biofeedback instruments
in the region. Asia Pacific is anticipated to register fastest growth rate
owing to rising medical tourism, improving access to healthcare services and
expansion of healthcare ecosystem in emerging countries such as India, China
and South Korea.
Key players operating in the biofeedback measurement instrument market are
Thought Technology Ltd, ELMIKO, Mind Media, Laborie, Behavioral Medicine
Associates, Inc, Neurocare Group Gmbh, Allengers Medical Systems, BrainMaster
Technologies, Inc, Quantum World Vision, NCC Medical, Qxsubspace. Thought
Technology Ltd and ELMIKO are recognized as industry leaders with wide range of
products and global sales footprint.
Get
more insights on this topic: https://www.newsstatix.com/biofeedback-measurement-instrument-market-share-and-opportunity-analysis-2023-2030/
Comments
Post a Comment